Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Estimated reading time for CME/CPD: 1 min

The Need for Continued Developments in Treating Paroxysmal Sympathetic Hyperactivity in Children

AI Summary
  • Ongoing research required to develop paediatric-specific treatments and high quality evidence for paroxysmal sympathetic hyperactivity management.
  • Current therapies are limited and heterogeneous, emphasising need for standardised protocols and clinical trials in children.
  • Early recognition, multidisciplinary care and long term follow up improve outcomes and guide treatment development.
Summarise with AI (MRCPsych/FRANZCP)

Hosp Pediatr. 2026 Nov 16:e2026009869. doi: 10.1542/hpeds.2026-009869. Online ahead of print.

NO ABSTRACT

PMID:43035108 | DOI:10.1542/hpeds.2026-009869

Document this CPD

Share Evidence Blueprint

QR Code

Save to Google Notes

Search Google Scholar

⭐ My Revision List

close chatgpt icon
ChatGPT

Enter your request.

← →
RAISR4D CME/CPD Evidence Nodes
Swipe to navigate RAISR4D CME/CPD evidence nodes.
CME/CPD